US Stock MarketDetailed Quotes

BioLine Rx (BLRX)

Watchlist
  • 2.270
  • -0.030-1.30%
Close Apr 24 16:00 ET
  • 2.270
  • 0.0000.00%
Post 20:01 ET
9.88MMarket Cap-7.94P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

BioLine Rx (BLRX) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
-95.92%1.18M
-98.35%194K
-91.36%427K
-94.36%304K
-96.28%255K
502.92%28.94M
144.77%11.75M
4.94M
5.39M
6.86M
Operating revenue
-95.92%1.18M
-98.35%194K
-91.36%427K
-94.36%304K
-96.28%255K
502.92%28.94M
144.77%11.75M
--4.94M
--5.39M
--6.86M
Cost of revenue
-97.52%230K
-99.34%40K
-89.78%84K
-91.97%72K
-97.66%34K
150.89%9.26M
64.92%6.09M
822K
897K
1.46M
Gross profit
-95.17%950K
-97.28%154K
-91.68%343K
-94.84%232K
-95.91%221K
1,675.90%19.68M
410.83%5.66M
4.12M
4.5M
5.4M
Operating expense
-71.06%11.24M
-59.91%3.54M
-73.18%2.55M
-75.31%2.54M
-74.45%2.61M
-11.95%38.83M
-31.93%8.83M
-23.06%9.51M
3.57%10.27M
15.42%10.22M
Selling and administrative expenses
-86.28%3.92M
-67.61%1.89M
-88.03%831K
-97.40%209K
-87.20%989K
-8.61%28.54M
-38.80%5.83M
-27.90%6.94M
16.43%8.04M
49.42%7.73M
-Selling and marketing expense
--0
--0
--0
--0
--0
-30.92%10.08M
-172.79%-8.23M
-31.71%5.55M
14.47%6.42M
63.71%6.34M
-General and administrative expense
-78.79%3.92M
-86.57%1.89M
-40.22%831K
-87.17%209K
-28.64%989K
10.96%18.46M
12.13%14.06M
-7.27%1.39M
24.83%1.63M
6.78%1.39M
Research and development costs
-11.54%8.09M
30.03%2.43M
-32.98%1.72M
4.54%2.33M
-34.92%1.62M
-26.92%9.15M
-39.88%1.87M
-5.94%2.57M
-25.98%2.23M
-32.30%2.49M
Depreciation amortization depletion
-91.76%28K
----
----
----
----
-3.13%340K
----
----
----
----
-Depreciation and amortization
-91.76%28K
----
----
----
----
-3.13%340K
----
----
----
----
Provision for doubtful accounts
-200.00%-800K
----
----
----
----
--800K
----
----
----
----
Operating profit
46.29%-10.29M
-6.81%-3.39M
59.03%-2.21M
60.11%-2.3M
50.41%-2.39M
55.45%-19.15M
73.28%-3.17M
56.41%-5.39M
41.78%-5.77M
45.55%-4.82M
Net non-operating interest income expense
97.86%-156K
92.44%-317K
106.13%73K
113.81%214K
65.38%-126K
-4,405.56%-7.3M
-354.18%-4.19M
-126.86%-1.19M
-72.80%-1.55M
6.67%-364K
Non-operating interest income
-38.24%1.12M
-112.94%-37K
-13.13%377K
-8.41%490K
-47.96%294K
-9.32%1.82M
-60.17%286K
39.10%434K
21.59%535K
5.21%565K
Non-operating interest expense
-86.21%1.25M
-94.34%251K
-81.29%304K
-86.76%276K
-54.79%420K
323.23%9.07M
563.43%4.44M
94.15%1.63M
55.95%2.09M
0.22%929K
Total other finance cost
-35.56%29K
----
----
----
----
80.00%45K
----
----
----
----
Other net income (expense)
-51.15%8.42M
-64.88%1.47M
53.04%1.16M
-123.71%-1.85M
70.24%7.64M
198.68%17.23M
213.78%4.18M
124.07%756K
200.96%7.81M
253.98%4.49M
Gain on sale of security
-52.99%8.94M
----
----
----
----
272.98%19.02M
----
----
----
----
Special income (charges)
--0
----
----
----
----
81.26%-1.26M
----
----
----
----
-Less:Impairment of capital assets
--0
----
----
----
----
-84.93%1.01M
----
----
----
----
-Less:Other special charges
----
----
----
----
----
--246K
----
----
----
----
Other non- operating income (expenses)
1.51%-522K
44.99%-7.47M
53.04%1.16M
-123.71%-1.85M
70.24%7.64M
-325.53%-530K
-196.85%-13.58M
124.07%756K
200.96%7.81M
253.98%4.49M
Income before tax
78.03%-2.03M
29.84%-2.24M
83.22%-977K
-914.05%-3.94M
836.64%5.13M
84.79%-9.22M
77.05%-3.19M
63.66%-5.82M
102.61%484K
94.28%-696K
Income tax
Net income
78.03%-2.03M
29.84%-2.24M
83.22%-977K
-914.05%-3.94M
836.64%5.13M
84.79%-9.22M
77.05%-3.19M
63.66%-5.82M
102.61%484K
94.28%-696K
Net income continuous Operations
78.03%-2.03M
29.84%-2.24M
83.22%-977K
-914.05%-3.94M
836.64%5.13M
84.79%-9.22M
77.05%-3.19M
63.66%-5.82M
102.61%484K
94.28%-696K
Minority interest income
-851K
Net income attributable to the parent company
87.26%-1.18M
56.54%-1.39M
83.22%-977K
-914.05%-3.94M
836.64%5.13M
84.79%-9.22M
77.05%-3.19M
63.66%-5.82M
102.61%484K
94.28%-696K
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
87.26%-1.18M
56.54%-1.39M
83.22%-977K
-914.05%-3.94M
836.64%5.13M
84.79%-9.22M
77.05%-3.19M
63.66%-5.82M
102.61%484K
94.28%-696K
Basic earnings per share
0
0
0
0
0
83.33%-6
0
0
0
0
Diluted earnings per share
0
0
0
0
0
83.33%-6
0
0
0
0
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue -95.92%1.18M-98.35%194K-91.36%427K-94.36%304K-96.28%255K502.92%28.94M144.77%11.75M4.94M5.39M6.86M
Operating revenue -95.92%1.18M-98.35%194K-91.36%427K-94.36%304K-96.28%255K502.92%28.94M144.77%11.75M--4.94M--5.39M--6.86M
Cost of revenue -97.52%230K-99.34%40K-89.78%84K-91.97%72K-97.66%34K150.89%9.26M64.92%6.09M822K897K1.46M
Gross profit -95.17%950K-97.28%154K-91.68%343K-94.84%232K-95.91%221K1,675.90%19.68M410.83%5.66M4.12M4.5M5.4M
Operating expense -71.06%11.24M-59.91%3.54M-73.18%2.55M-75.31%2.54M-74.45%2.61M-11.95%38.83M-31.93%8.83M-23.06%9.51M3.57%10.27M15.42%10.22M
Selling and administrative expenses -86.28%3.92M-67.61%1.89M-88.03%831K-97.40%209K-87.20%989K-8.61%28.54M-38.80%5.83M-27.90%6.94M16.43%8.04M49.42%7.73M
-Selling and marketing expense --0--0--0--0--0-30.92%10.08M-172.79%-8.23M-31.71%5.55M14.47%6.42M63.71%6.34M
-General and administrative expense -78.79%3.92M-86.57%1.89M-40.22%831K-87.17%209K-28.64%989K10.96%18.46M12.13%14.06M-7.27%1.39M24.83%1.63M6.78%1.39M
Research and development costs -11.54%8.09M30.03%2.43M-32.98%1.72M4.54%2.33M-34.92%1.62M-26.92%9.15M-39.88%1.87M-5.94%2.57M-25.98%2.23M-32.30%2.49M
Depreciation amortization depletion -91.76%28K-----------------3.13%340K----------------
-Depreciation and amortization -91.76%28K-----------------3.13%340K----------------
Provision for doubtful accounts -200.00%-800K------------------800K----------------
Operating profit 46.29%-10.29M-6.81%-3.39M59.03%-2.21M60.11%-2.3M50.41%-2.39M55.45%-19.15M73.28%-3.17M56.41%-5.39M41.78%-5.77M45.55%-4.82M
Net non-operating interest income expense 97.86%-156K92.44%-317K106.13%73K113.81%214K65.38%-126K-4,405.56%-7.3M-354.18%-4.19M-126.86%-1.19M-72.80%-1.55M6.67%-364K
Non-operating interest income -38.24%1.12M-112.94%-37K-13.13%377K-8.41%490K-47.96%294K-9.32%1.82M-60.17%286K39.10%434K21.59%535K5.21%565K
Non-operating interest expense -86.21%1.25M-94.34%251K-81.29%304K-86.76%276K-54.79%420K323.23%9.07M563.43%4.44M94.15%1.63M55.95%2.09M0.22%929K
Total other finance cost -35.56%29K----------------80.00%45K----------------
Other net income (expense) -51.15%8.42M-64.88%1.47M53.04%1.16M-123.71%-1.85M70.24%7.64M198.68%17.23M213.78%4.18M124.07%756K200.96%7.81M253.98%4.49M
Gain on sale of security -52.99%8.94M----------------272.98%19.02M----------------
Special income (charges) --0----------------81.26%-1.26M----------------
-Less:Impairment of capital assets --0-----------------84.93%1.01M----------------
-Less:Other special charges ----------------------246K----------------
Other non- operating income (expenses) 1.51%-522K44.99%-7.47M53.04%1.16M-123.71%-1.85M70.24%7.64M-325.53%-530K-196.85%-13.58M124.07%756K200.96%7.81M253.98%4.49M
Income before tax 78.03%-2.03M29.84%-2.24M83.22%-977K-914.05%-3.94M836.64%5.13M84.79%-9.22M77.05%-3.19M63.66%-5.82M102.61%484K94.28%-696K
Income tax
Net income 78.03%-2.03M29.84%-2.24M83.22%-977K-914.05%-3.94M836.64%5.13M84.79%-9.22M77.05%-3.19M63.66%-5.82M102.61%484K94.28%-696K
Net income continuous Operations 78.03%-2.03M29.84%-2.24M83.22%-977K-914.05%-3.94M836.64%5.13M84.79%-9.22M77.05%-3.19M63.66%-5.82M102.61%484K94.28%-696K
Minority interest income -851K
Net income attributable to the parent company 87.26%-1.18M56.54%-1.39M83.22%-977K-914.05%-3.94M836.64%5.13M84.79%-9.22M77.05%-3.19M63.66%-5.82M102.61%484K94.28%-696K
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 87.26%-1.18M56.54%-1.39M83.22%-977K-914.05%-3.94M836.64%5.13M84.79%-9.22M77.05%-3.19M63.66%-5.82M102.61%484K94.28%-696K
Basic earnings per share 0000083.33%-60000
Diluted earnings per share 0000083.33%-60000
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion with Explanatory Notes--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +16.17%
Sample Name
Sample Code
 +12.91%
Sample Name
Sample Code
 +12.09%
4
VanEck Oil Services ETF
OIH
+5.81%
5
ProShares Ultra Bloomberg Crude Oil ETF
UCO
+4.91%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +12.90%
Sample Name
Sample Code
 +11.93%
Sample Name
Sample Code
 +8.63%
4
United Microelectronics
UMC
+5.32%
5
Chagee Holdings
CHA
+3.37%
View More
Middle East conflict spreads to the stock market! How should investors respond?
Signs of restarting the second round of US-Iran talks have emerged. According to reports, Iran's foreign minister arrived in Pakistan on Fri Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -